Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice

NCT ID: NCT01446146

Last Updated: 2013-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this program is to compare two different methods of matching a Veteran to a PTSD treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Posttraumatic Stress Disorder (PTSD) is a serious disorder that affects many Veterans who have had a traumatic experience. The VA offers several different types of treatment for PTSD. We are researching different ways to match a Veteran to a type of treatment. Participants in this study will will be randomly assigned to either a 40-minute session in which they will learn about PTSD treatments and select a preferred treatment or to a 40-minute assessment interview. Those participants assigned to the assessment interview will have the opportunity to work with their Trauma Recovery Program provider to determine a plan for their PTSD treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posttraumatic Stress Disorder (PTSD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IDM intervention

Will receive a 40 minute intervention session with a clinician, learning about PTSD treatment options and choosing a preferred treatment.

Group Type EXPERIMENTAL

Informed decision making

Intervention Type BEHAVIORAL

40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.

Treatment as usual plus placebo session

Will work with provider to select a treatment plan and will receive a 40 minute session without IDM intervention.

Group Type PLACEBO_COMPARATOR

Placebo session

Intervention Type BEHAVIORAL

Participant will complete clinician-administered measures in a 40-minute session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Informed decision making

40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.

Intervention Type BEHAVIORAL

Placebo session

Participant will complete clinician-administered measures in a 40-minute session.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of combat-related PTSD
* Newly enrolled in Trauma Recovery Program (TRP) at the Michael E. DeBakey VA medical center
* TRP provider approval

Exclusion Criteria

* Previous participation in TRP treatment for PTSD
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

South Central VA Mental Illness Research, Education & Clinical Center

FED

Sponsor Role collaborator

Michael E. DeBakey VA Medical Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Juliette Mott

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juliette M Mott, PhD

Role: PRINCIPAL_INVESTIGATOR

MDVAMC, BCM, SC MIRECC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Michael E. DeBakey VA Medical Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-28111

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.